Florence De Fraipont Selected Research

Florence De Fraipont Research Topics

3	Neoplasms (Cancer) 01/2020 - 10/2012
3	Melanoma (Melanoma, Malignant) 01/2020 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 04/2010
3	Stroke (Strokes) 12/2016 - 01/2009
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2016 - 01/2014
1	Ischemic Stroke 01/2014
1	Sarcoma (Soft Tissue Sarcoma) 10/2012

4	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2012
3	Tyrosine Kinase InhibitorsIBA 01/2019 - 04/2010
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2019 - 10/2012
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019
1	CytokinesIBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 12/2016
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2014
1	Angiopoietin-2IBA 01/2014
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2014
1	Immunoglobulins (Immunoglobulin)IBA 01/2014
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2014
1	Endothelial Growth FactorsIBA 01/2014
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2014
1	Chemokine ReceptorsIBA 01/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2014
1	DNA (Deoxyribonucleic Acid)IBA 10/2012
1	Epidermal Growth Factor (EGF)IBA 10/2012
1	ErbB Receptors (EGF Receptor)IBA 04/2010

1	Immunotherapy 01/2019
1	Intravenous Injections 12/2016
1	Therapeutics 01/2014
1	Intravenous Administration 01/2009
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2009